Torrent Pharmaceuticals Share Price Gains 1.91% After Q1 Results
- July 31, 2026
- Posted by: Neeraj Pandey
- Category: News
Torrent Pharmaceuticals gains 1.91% to Rs 4,965.00. Q1 FY27 PAT Rs 566 crore vs Rs 548 crore (+3.3% YoY). Revenue Rs 4,921 crore vs Rs 3,178 crore (+55% YoY).
The Torrent Pharmaceuticals share price gain after Q1 results theme was in focus on Friday, with Torrent Pharmaceuticals shares moving 1.91% to Rs 4,965.00, from a previous close of Rs 4,872.10, after the company reported its results for the quarter ended June 2026.
Torrent Pharmaceuticals reported a profit after tax of Rs 566 crore for Q1 FY27, against Rs 548 crore in the year-ago quarter, a change of +3.3%. Revenue for the quarter stood at Rs 4,921 crore, compared with Rs 3,178 crore a year earlier, a change of +55%.
Click Here – Get Free Investment Predictions
Torrent Pharmaceuticals Q1 FY27 Results: Key Numbers
| Metric | Q1 FY27 | Q1 FY26 | YoY Change |
|---|---|---|---|
| Profit After Tax | Rs 566 crore | Rs 548 crore | +3.3% |
| Revenue | Rs 4,921 crore | Rs 3,178 crore | +55% |
Why Torrent Pharmaceuticals Shares Moved 1.91% Today
Check the Univest Screener for sector-linked stocks
Revenue jumped sharply on the JB Pharma acquisition and strong India business, with margin building offset by integration and one-off costs.
About Torrent Pharmaceuticals
Ahmedabad-based pharma major ranked among India’s top companies in cardiac, GI and CNS therapies.
Download the Univest iOS App or Univest Android App to track Torrent Pharmaceuticals’s stock price and quarterly results.
What to Watch Going Forward
Investors tracking Torrent Pharmaceuticals should watch management commentary on demand trends, cost pressures and full-year guidance in the coming quarters, since forward-looking statements often matter as much as the headline quarterly numbers for how the stock trades over the following weeks.
Conclusion
The Torrent Pharmaceuticals share price gain after Q1 results move reflects the market’s reaction to the company’s latest quarterly performance. Investors should evaluate the stock against its own growth trajectory and valuation, and consult a SEBI-registered financial advisor before making any investment decision.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Investors continuing to track the Torrent Pharmaceuticals share price gain after Q1 results story should watch how the stock trades in the sessions ahead.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Torrent pharmaceuticals share price gain after q1 results
Why did Torrent Pharmaceuticals share price gain after Q1 results?
Ans. Torrent Pharmaceuticals shares moved 1.91% after the company reported Q1 FY27 profit after tax of Rs 566 crore, a change of +3.3% from Rs 548 crore a year earlier, on revenue of Rs 4,921 crore.
What was Torrent Pharmaceuticals’s profit in Q1 FY27?
Ans. Torrent Pharmaceuticals reported a profit after tax of Rs 566 crore for the quarter ended June 2026, compared with Rs 548 crore in the same quarter a year earlier.
What was Torrent Pharmaceuticals’s revenue in Q1 FY27?
Ans. Torrent Pharmaceuticals’s revenue for Q1 FY27 stood at Rs 4,921 crore, compared with Rs 3,178 crore a year earlier, a change of +55%.
What is Torrent Pharmaceuticals’s current share price?
Ans. Torrent Pharmaceuticals shares were trading at Rs 4,965.00 today, gaining 1.91% from the previous close of Rs 4,872.10.
Should I buy Torrent Pharmaceuticals shares after the Q1 results move?
Ans. Investment decisions should be based on individual research and risk appetite; consult a SEBI-registered financial advisor before buying or selling shares after any results-driven move.
Where can I track Torrent Pharmaceuticals’s live share price?
Ans. Torrent Pharmaceuticals’s live share price and quarterly result updates can be tracked on the Univest platform alongside SEBI-registered research.
